You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Details for New Drug Application (NDA): 020802


✉ Email this page to a colleague

« Back to Dashboard


NDA 020802 describes EXCEDRIN (MIGRAINE RELIEF), which is a drug marketed by Haleon Us Holdings and is included in one NDA. It is available from four suppliers. Additional details are available on the EXCEDRIN (MIGRAINE RELIEF) profile page.

The generic ingredient in EXCEDRIN (MIGRAINE RELIEF) is acetaminophen; aspirin; caffeine. There are sixty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; aspirin; caffeine profile page.
Summary for 020802
Suppliers and Packaging for NDA: 020802
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EXCEDRIN (MIGRAINE RELIEF) acetaminophen; aspirin; caffeine TABLET;ORAL 020802 NDA Haleon US Holdings LLC 0067-2035 0067-2035-20 1 BOTTLE in 1 CARTON (0067-2035-20) / 20 TABLET, COATED in 1 BOTTLE
EXCEDRIN (MIGRAINE RELIEF) acetaminophen; aspirin; caffeine TABLET;ORAL 020802 NDA Haleon US Holdings LLC 0067-2035 0067-2035-80 1 BOTTLE in 1 CARTON (0067-2035-80) / 80 TABLET, COATED in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength250MG;250MG;65MG
Approval Date:Jan 14, 1998TE:RLD:Yes

Expired US Patents for NDA 020802

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Haleon Us Holdings EXCEDRIN (MIGRAINE RELIEF) acetaminophen; aspirin; caffeine TABLET;ORAL 020802-001 Jan 14, 1998 ⤷  Sign Up ⤷  Sign Up
Haleon Us Holdings EXCEDRIN (MIGRAINE RELIEF) acetaminophen; aspirin; caffeine TABLET;ORAL 020802-001 Jan 14, 1998 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.